Active Ingredient: ROFLUMILAST
Proprietary Name: ROFLUMILAST
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MCG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A208272
Product Number: 001
Approval Date: Aug 6, 2018
Applicant Holder Full Name: TORRENT PHARMACEUTICALS LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information
